Xbrane Biopharma AB 2025 Integrated Report
Company: Xbrane Biopharma AB
Sector: Manufacturing
Country: Sweden
Year: 2025
Type: Integrated Report
Pages: 84
The report describes Xbrane's 2025 sustainability work following the divestment of its internal R&D operations and one development program. It reports 29 employees at year-end, operational gross GHG emissions of 3 t CO2e, and a double materiality assessment covering environmental, social and governance topics. Ximluci® was associated with treatment for approximately 11,000 patients and estimated savings of EUR 20 m for society.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.